Abstract LB-C08: Imipridone ONC212 induces apoptosis, suppresses autophagy and synergizes upon GRP132 knockdown or exposure to lactic acid in preclinical studies of the pancreatic cancer microenvironment

MLA

Isacco Ferrarini, et al. “Abstract LB-C08: Imipridone ONC212 Induces Apoptosis, Suppresses Autophagy and Synergizes upon GRP132 Knockdown or Exposure to Lactic Acid in Preclinical Studies of the Pancreatic Cancer Microenvironment.” Molecular Cancer Therapeutics, vol. 18, Dec. 2019, p. LB-C08. EBSCOhost, https://doi.org/10.1158/1535-7163.targ-19-lb-c08.

APA

Isacco Ferrarini, Howard Safran, Aakash Jhaveri, Lanlan Zhou, Young Lee, & Wafik S. El-Deiry. (2019). Abstract LB-C08: Imipridone ONC212 induces apoptosis, suppresses autophagy and synergizes upon GRP132 knockdown or exposure to lactic acid in preclinical studies of the pancreatic cancer microenvironment. Molecular Cancer Therapeutics, 18, LB-C08. https://doi.org/10.1158/1535-7163.targ-19-lb-c08

Chicago

Isacco Ferrarini, Howard Safran, Aakash Jhaveri, Lanlan Zhou, Young Lee, and Wafik S. El-Deiry. 2019. “Abstract LB-C08: Imipridone ONC212 Induces Apoptosis, Suppresses Autophagy and Synergizes upon GRP132 Knockdown or Exposure to Lactic Acid in Preclinical Studies of the Pancreatic Cancer Microenvironment.” Molecular Cancer Therapeutics 18 (December): LB-C08. doi:10.1158/1535-7163.targ-19-lb-c08.